RetractedTrialJournal of the National Cancer Institute2023

Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer.

Xiao-Shan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.